Adam Ang
It features more than 1,200 combinations of randomised simulated situations in a hospital ward.
The company also has pending approvals for the device in Australia and Thailand.
The online treatment has been licensed to Blue Note Therapeutics for the development of a counterpart version in North America.
Also, engineers from the University of Hong Kong have come up with a tiny biosensing platform for personalised health monitoring.
It will soon launch its mobile app on Android and iOS devices.
It is integrated with medical IoT devices that can screen up to 16 vital parameters.
It measures the cortical thickness in a brain scan to provide a patient's level of brain ageing.
The clearance signals the company's move to offer medical AI devices to consumers.
It also plans to double its headcount over the next 12 months.
Also, US-based healthcare cloud solutions provider Healthcare Triangle has expanded to Asia-Pacific.